����������ý�Ļ���Ʒ

Imagine a test that could tell you if you were infected with COVID-19 before you had a single symptom, came at an affordable price without the need to go to a doctor, and returned results in minutes. That’s the vision behind a new CU-born technology.

ALD NanoSolutions, a ����������ý�Ļ���Ʒ spinout company and one of the leading experts on atomic layer deposition (ALD), has merged with Louisville, CO-based Forge Nano to commercialize its cutting edge surface engineering techniques.

In hopes of securing investments to advance their companies, 18 university ventures spun out of Colorado research institutions and federal laboratories pitched to local and out-of-state investors at the state's second annual Destination Startup showcase.

According to the journal, Professor Randolph and long-time collaborator Professor John Carpenter have shared their expertise in proteins with the drug development industry and guided regulatory strategies, among many other accomplishments.

Destination Startup, a collaboration among Front Range research universities and federal laboratories, connects Colorado’s most promising ventures with funding and networking opportunities so they can take the next step toward commercialization.

This year's event — hosted again by Venture Partners at ����������ý�Ļ���Ʒ on Feb. 27 — will feature 18 startups from ����������ý�Ļ���Ʒ, CU Anschutz, CU Denver, University of Colorado Colorado Springs, Colorado State University, Colorado School of Mines and NIST. 

Using algorithms originally developed for financial forecasting, Arpeggio reconstructs the biological network a drug affects and identifies the genes critical for the success or failure of a drug.

Using algorithms originally developed for financial forecasting, Arpeggio's technology reconstructs the biological network that a drug affects and identifies the genes critical for the success or failure of a drug.

Competing against companies from across the entire state, six ����������ý�Ļ���Ʒ startups won a total of $1.5M in grants from the Colorado Office of Economic Development and International Trade (OEDIT)'s Advanced Industries Accelerator (AIA) Program.

Inscripta, a digital genome engineering company spun out of ����������ý�Ļ���Ʒ research, has just raised another $125 million in a Series D financing on the heels of launching its revolutionary product, The Onyx™.